The Valley Desk

NCT06319170 · Interventional trial

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Overall registry status Completed

Phase 1

Conditions Schizophrenia, Schizoaffective Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov